| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1045435366 |
| P356 | DOI | 10.1007/S12094-014-1258-7 |
| P698 | PubMed publication ID | 25445175 |
| P2093 | author name string | J Lee | |
| S T Kim | |||
| W K Kang | |||
| I Sohn | |||
| K-M Kim | |||
| I-G Do | |||
| P2860 | cites work | The protein kinase complement of the human genome | Q24324497 |
| Targeting the hepatocyte growth factor-cMET axis in cancer therapy | Q24606259 | ||
| Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. | Q27824766 | ||
| Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial | Q27851578 | ||
| Oncogenic kinase signalling | Q28189493 | ||
| HER2 testing in gastric cancer: a practical approach | Q28256814 | ||
| A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers | Q28485310 | ||
| Direct multiplexed measurement of gene expression with color-coded probe pairs | Q29614417 | ||
| Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer | Q29616236 | ||
| Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors | Q29618610 | ||
| Epidemiology of gastric cancer in Japan | Q34559042 | ||
| Impact of HER-2 overexpression/amplification on the prognosis of gastric cancer patients undergoing resection: a single-center study of 1,036 patients | Q35642359 | ||
| MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib | Q35666332 | ||
| Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. | Q35877741 | ||
| Blockade of epidermal growth factor receptor (EGFR) activity. | Q36046504 | ||
| Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view | Q36626030 | ||
| Personalizing therapies for gastric cancer: molecular mechanisms and novel targeted therapies | Q37241496 | ||
| The emerging role of MET/HGF inhibitors in oncology | Q38085900 | ||
| Prognostic role of human epidermal growth factor receptor in gastric cancer: a systematic review and meta-analysis | Q38122908 | ||
| HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells | Q39922969 | ||
| Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients | Q44216566 | ||
| MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas | Q46799794 | ||
| Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization | Q46859748 | ||
| Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target. | Q53259972 | ||
| Genetic activation of the MET pathway and prognosis of patients with high-risk, radically resected gastric cancer. | Q54341358 | ||
| ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of gastric cancer | Q61868158 | ||
| Patterns of failure following curative resection of gastric carcinoma | Q68637468 | ||
| Recurrence following curative resection for gastric carcinoma | Q73442414 | ||
| c-Met expression in gastric cancer with liver metastasis | Q78378659 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 462-468 | |
| P577 | publication date | 2014-12-02 | |
| P1433 | published in | Clinical and Translational Oncology | Q15754324 |
| P1476 | title | The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer. | |
| P478 | volume | 17 |
| Q37017215 | A Family of non-GPCR Chemosensors Defines an Alternative Logic for Mammalian Olfaction |
| Q55322124 | A novel dual-marker expression panel for easy and accurate risk stratification of patients with gastric cancer. |
| Q42371631 | Development of mesenchymal subtype gene signature for clinical application in gastric cancer |
| Q35815161 | Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecan |
| Q38749038 | Gastric cancer management: Kinases as a target therapy |
| Q41077332 | The Clinical Impact of c-MET Over-Expression in Advanced Biliary Tract Cancer (BTC). |
| Q99578051 | mRNA expression in low grade serous ovarian cancer: Results of a nanoString assay in a diverse population |
Search more.